MCCC2 유전자의 새로운 변이에 의한 3-Methylcrotonyl-CoA Carboxylase 결핍증
Identification of a Novel Mutation in the MCCC2 Gene of a Korean Patient with 3-Methylcrotonyl-CoA Carboxylase Deficiency
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
3-methylcrotonyl-CoA carboxylase deficiency is an autosomal recessive disorder characterized by a defect in leucine catabolism. We report the case of an 80-day-old patient with 3-methylcrotonyl-CoA carboxylase deficiency who had elevated levels of 3-hydroxyisovalerylcarnitine (45.56μmol/L; reference range, <0.65 μmol/L), which was detected using tandem mass spectrometry during newborn screening, and elevated levels of 3-hydroxyisovaleric acid (375.75 mmol/mol Cr) and 3-methylcrotonylglycine (502.36 mmol/mol Cr ), which were detected in urine organic acid analysis. We performed direct sequence analysis of all the exons of the MCCC1 and MCCC2 genes. No mutations were detected in the direct sequence analysis of MCCC1. However sequencing of the MCCC2 gene revealed a mutation caused by a heterozygous G to C transversion [c.313G>C (p.Gly105Arg)] at nucleotide position 313 and a mutation caused by a heterozygous A to T transversion [c.1252A>T (p.lle418Phe)] at nucleotide position 1252. Identification of these 2 novel MCCC2 gene mutations in our patient suggested that analysis of the MCCC1 and MCCC2 genes might prove useful in the diagnosis of 3-methylcrotonyl-CoA carboxylase deficiency.
Abstract
3-methylcrotonyl-CoA carboxylase deficiency is an autosomal recessive disorder characterized by a defect in leucine catabolism. We report the case of an 80-day-old patient with 3-methylcrotonyl-CoA carboxylase deficiency who had elevated levels of 3-hydroxyisovalerylcarnitine (45.56μmol/L; reference range, <0.65 μmol/L), which was detected using tandem mass spectrometry during newborn screening, and elevated levels of 3-hydroxyisovaleric acid (375.75 mmol/mol Cr) and 3-methylcrotonylglycine (502.36 mmol/mol Cr ), which were detected in urine organic acid analysis. We performed direct sequence analysis of all the exons of the MCCC1 and MCCC2 genes. No mutations were detected in the direct sequence analysis of MCCC1. However sequencing of the MCCC2 gene revealed a mutation caused by a heterozygous G to C transversion [c.313G>C (p.Gly105Arg)] at nucleotide position 313 and a mutation caused by a heterozygous A to T transversion [c.1252A>T (p.lle418Phe)] at nucleotide position 1252. Identification of these 2 novel MCCC2 gene mutations in our patient suggested that analysis of the MCCC1 and MCCC2 genes might prove useful in the diagnosis of 3-methylcrotonyl-CoA carboxylase deficiency.
참고문헌 (24)
- Stadler SC, "Newborn screening for 3-methylcrotonyl-CoA carboxylase deficiency: population heterogeneity of MCCA and MCCB mutations and impact on risk assessment", Hum Mutat, 27, pp.748~759 (2006)
- Naylor EW, "Automated tandem mass spectrometry for mass newborn screening for disorders in fatty acid, organic acid and amino acid metabolism", J Child Neurol, 14, pp.4~8 (1999)
- Gibson KM, "3-Methylcrotonyl-coenyme A carboxylase deficiency in Amish", Mennonite adults identified by detection of increased acylcarnitines in blood spots of their children, 1998, pp.132, 519~523
- Smith WE, "Evaluation of elevated hydroxyisovalerylcarnitine in the newborn screen by tandem mass spectrometry", Am J Hum Genet, 67, pp.292~ (2000)
- Arnold GL, "A delphi-based consensus clinical practice protocol for the diagnosis and management of 3-methylcrotonyl CoA carboxylase deficiency", Mol Genet Metab, 93, pp.363~370 (2008)
- Uematsu M, "Novel mutations in five Japanese patients with 3-methylcrotonyl-CoA carboxylase deficiency", J Hum Genet, 52, pp.1040~1043 (2007)
- 김진경, "Tandem Mass Spectrometry를 이용한 신생아 선별검사로 발견된 무증상의 3-methylcrotonylglycinuria 1례", Korean Journal of Pediatrics, 47(8), pp.912~916 (2004), 대한소아과학회
- Lehnert W, "Isolated biotin-resistant 3-methylcrotonyl-CoA carboxylase deficiency: long-term outcome in a case with neonatal onset", Eur J Pediatr, 155, pp.568~572 (1996)
- Murayama K, "Isolated 3-methylcrotonyl-CoA carboxylase deficiency in a 15-year-old girl", Brain Dev, 19, pp.303~305 (1997)
- Bartlett K, "Isolated biotin-resistant 3-methylcrotonyl CoA carboxylase deficiency presenting with life-threatening hypoglycaemia", J Inherit Metab Dis, 7, pp.182~ (1984)
- Gitzelmann R, "Baumgartner ER. Isolated biotin-resistant 3-methylcrotonyl CoA carboxylase deficiency presenting at age 20 months with sopor, hypoglycaemia and ketoacidosis", J Inherit Metab Dis, 10, pp.290~292 (1987)
- Wilcken B, "Screening newborns for inborn errors of metabolism by tandem mass spectrometry", N Engl J Med, 348, pp.2304~2312 (2003)
- Koeberl DD, "Evaluation of 3-methylcrotonyl-CoA carboxylase deficiency detected by tandem mass spectrometry newborn screening", J Inherit Metab Dis, 26, pp.25~35 (2003)
- Eichhorst J, "Elevated neonatal 3-OH isovalerylcarnitine due to breast milk sources in maternal 3-MCC deficiency", Mol Genet Metab, 101, pp.84~86 (2010)
- Yap S, "Late-infantile 3-methylcrotonyl- CoA carboxylase deficiency presenting as global developmental delay", J Inherit Metab Dis, 21, pp.175~176 (1998)
- Lamhonwah AM, "Isolation of cDNA clones coding for the α and β chains of human propionyl-CoA carboxylase: chromosomal assignments and DNA polymorphisms associated with PCCA and PCCB genes", Proc Natl Acad Sci USA, 83, pp.4864~4868 (1986)
- Gallardo ME, "The molecular basis of 3-methylcrotonylglycinuria, a disorder of leucine catabolsim", Am J Hum Genet, 68, pp.334~346 (2001)
- Eminoglu FT, "3-Methylcrotonyl-CoA carboxylase deficiency: phenotypic variability in a family", J Child Neurol, 24, pp.478~481 (2009)
- Stucki M, "Cryptic exon activation by disruption of exon splice enhancer: novel mechanism causing 3-methylcrotonyl-CoA carboxylase deficiency", J Biol Chem, 284, pp.28953~28957 (2009)
- Nguyen KV, "Novel mutations in the human MCCA and MCCB gene causing methylcrotonylglycinuria" (2010), Mol Genet Metab
- Desviat LR, "Functional analysis of MCCA and MCCB mutations causing methylcrotonylglycinuria", Mol Genet Metab, 80, pp.315~320 (2003)
- Baumgartner MR, "The molecular basis of human 3-methylcrotonyl-CoA carboxylase deficiency", J Clin Invest, 107, pp.495~504 (2001)
- Dantas MF, "3-Methylcrotonyl-CoA carboxylase deficiency: mutation analysis in 28 probands, 9 symptomatic and 19 detected by newborn screening", Hum Mutat, 26, pp.164~ (2005)
- Ficicioglu C, "3-Methylcrotonyl-CoA carboxylase deficiency: metabolic decompensation in a noncompliant child detected through newborn screening", Pediatrics, 118, pp.2555~2556 (2006)